DONEGAN, JAMES J.;DIAMOND, PAUL;ENZO BIOCHEM, INC.;ELAZAR, RABBANI
发明人:
ELAZAR, RABBANI,DONEGAN, JAMES J.,DIAMOND, PAUL
申请号：
CA3061201
公开号：
CA3061201A1
申请日:
2018.06.25
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The invention provides methods and compositions for treating cancers and myeloproliferative disorders using sphingosine kinase-1 inhibitors, such as SK1-I, and selective sphingosine- 1 -phosphate receptor agonists, such as ozanimod.
